Which Is the Better International ETF, iShares' IEFA or State Street's SPGM?

SPGM vs. IEFA is a comparison of two low-cost international ETFs: IEFA has the lower expense ratio at 0.07% vs. 0.09% and a higher dividend yield of 3.5% vs. 1.8%, while SPGM delivered the stronger 1-year return at 43.0% vs. 31.3%. Over five years, SPGM also showed a shallower max drawdown (-25.92% vs. -30.41%) and better growth of $1,000 ($1,684 vs. $1,527). The article is largely informational, highlighting different geographic exposures, with IEFA focused on developed markets outside North America and SPGM offering broader global exposure with a tech tilt.

Analysis

The real distinction here is not “cheap international exposure” versus “cheaper international exposure,” but factor architecture. SPGM’s broader global/tech-heavy mix means it is already partly a U.S. large-cap growth proxy in disguise, so it will tend to outperform in liquidity-driven, AI-led risk-on tapes and underperform if mega-cap tech momentum stalls. IEFA is the cleaner currency and policy bet: more direct exposure to Europe/Japan/UK balance sheets, more dividend carry, and more sensitivity to FX and rate differentials than to U.S. tech multiple expansion.

That creates a second-order winner/loser map. If U.S. leadership broadens, SPGM benefits because it owns the firms with the highest operating leverage to global earnings and index flows; if the market rotates toward value, financials, and industrial cyclicals, IEFA should catch up because its sector mix is less duration-sensitive and more exposed to nominal growth outside the U.S. The flip side is that SPGM may look better on a 12-month chart precisely when it is becoming more crowded and more correlated with the same U.S. names investors already own elsewhere.

The key risk for IEFA is not just “higher drawdown,” but FX translation: a stronger dollar can erase the apparent yield advantage quickly, especially over a 3-6 month horizon. For SPGM, the hidden risk is concentration through the back door — the broader basket still leaves performance hostage to the same few U.S. tech winners, so any AI digestion phase could hit returns even if global equities are fine. That makes the current performance gap less about structural superiority and more about timing a factor cycle that may not persist.

Consensus is probably underestimating how much of SPGM’s relative strength is beta to the U.S. tech complex, not superior global diversification. If the market starts paying for cash flow and dividends rather than long-duration growth, IEFA’s lower fee plus higher income stream can outperform on a total-return basis despite weaker momentum. Conversely, if the dollar rolls over and global risk appetite improves, IEFA could re-rate faster than the headline drawdown profile implies because its earnings are more directly levered to currency relief and cyclicals.

Key Decisions for Investors

• Use SPGM as the tactical vehicle for a continued AI/liquidity-led risk-on view over the next 1-3 months; trim if U.S. mega-cap tech breadth narrows or semis lead to a weaker tape, since the trade is effectively long U.S. growth embedded in an international wrapper.
• Build IEFA on pullbacks for a 6-12 month mean-reversion trade if the dollar softens; target a rotation into value/cyclical and dividend exposure with better carry, but size smaller than SPGM because FX can dominate near-term returns.
• Pair trade: long IEFA / short a U.S. growth proxy such as QQQ if rates back up or AI multiples compress; risk/reward improves if the market shifts from duration to cash-flow pricing over the next quarter.
• For income-oriented accounts, prefer IEFA over SPGM and hedge part of the FX exposure with dollar strength overlays if the DXY trend remains upward; the yield pickup can be partially neutralized by USD appreciation within one to two quarters.
• Avoid adding both funds simultaneously; they are overlapping exposures with different wrapping. Choose SPGM for momentum-sensitive global equity beta, IEFA for income/currency/cyclicals, and reassess after the next Fed/dollar inflection.